Wells Fargo
OMIC

Wells Fargo’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Wells Fargo’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13
Closed -$197 – 7660
2024
Q1 		$197 Hold
13
– – ﹤0.01% 6499
2023
Q4 		$173 Buy
13
+1
+8% +$12 ﹤0.01% 6643
2023
Q3 		$136 Buy
12
+1
+9% +$19 ﹤0.01% 6685
2023
Q2 		$262 Sell
11
-321
-97% -$9.4K ﹤0.01% 6626
2023
Q1 		$12K Sell
332
-966
-74% -$59.2K ﹤0.01% 5799
2022
Q4 		$78.2K Sell
1,298
-20
-2% -$1.34K ﹤0.01% 4663
2022
Q3 		$99K Sell
1,318
-26
-2% -$2.72K ﹤0.01% 4606
2022
Q2 		$154K Buy
1,344
+1,234
+1,122% +$145K ﹤0.01% 4421
2022
Q1 		$21K Buy
110
+100
+1,000% +$23.1K ﹤0.01% 5998
2021
Q4 		$3K Buy
10
+8
+400% +$3.1K ﹤0.01% 6837
2021
Q3 		$1K Buy
+2
New +$1.03K ﹤0.01% 6836

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Wells Fargo's OMIC Position: Q2 2024 in Review

Wells Fargo sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 13 shares — an estimated $197 sold.

Wells Fargo first reported a position in OMIC in Q3 2021 and held it in 11 quarters. The position peaked at $154K in Q2 2022. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Wells Fargo reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 13 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $197.
  • Wells Fargo first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Wells Fargo's Singular Genomics Systems, Inc. Common Stock position peaked at $154K in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.